根据机器学习算法,基于机械心脏门更换后患者稳定的华法林剂量的预测模型
Bowen Guo1, Cong Chen1, Junhang Jia1
1Center of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, 100000 Beijing, China.
Reviews in cardiovascular medicine
|July 9, 2025
概括
这项研究开发了一种机器学习模型,用于预测机械心脏门患者的稳定华法林剂量. 支持矢量机辐射基函数 (SVM Radial) 算法实现了高精度,改善了个性化的华法林剂量.
科学领域:
- 药物基因组学 药物基因组学
- 机器学习在医学中的应用
- 心血管外科心血管外科
背景情况:
- 华法林的剂量由于其狭窄的治疗范围和个体间的变化而具有挑战性.
- 针对华法林的个性化药物需要整合临床和遗传因素.
研究的目的:
- 开发和验证一种机器学习模型,用于预测北中国患者机械心脏门置换后稳定的华法林剂量.
- 将各种机器学习算法的性能与传统模型进行比较.
主要方法:
- 收集了413名接受机械心脏门置换的患者的临床和遗传数据.
- 使用培训/验证分割 (8:2) 和协变性分析 (ANCOVA) 进行变量选择.
- 使用线性,通用线性 (GLM) 和10个机器学习算法 (包括SVM Radial) 构建预测模型.
主要成果:
- 支持矢量机器辐射基函数 (SVM Radial) 算法表现出卓越的性能.
- 在SVM Radial的研究中,R平方值为0.98,平均绝对误差为0.14mg/day.
- 该模型在不同剂量组中的93.83%的患者中准确预测了理想的华法林剂量.
结论:
- 与以前的方法相比,SVM Radial模型在预测华法林维持剂量方面提供了显著更高的准确性.
- 这种方法显示出在个性化华法林治疗中广泛临床应用的潜力.
- 建议使用更大的多中心数据集进行进一步验证,以确认模型的预测准确性.
更多相关视频
09:57Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement
Published on: January 20, 2022
2.8K
07:46Author Spotlight: Revolutionizing Remote Surgery with Augmented Reality and Robotics for Enhanced Precision and Accessibility
Published on: August 9, 2024
853
相关概念视频
Venous Thrombosis III: Interprofessional Care
26
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
26
Mitral Valve Prolapse II: Assessment and Management
44
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
44
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
